Tags

Type your tag names separated by a space and hit enter

Stereotactic breast biopsy in a community hospital setting.
Am Surg. 1999 Aug; 65(8):737-40; discussion 740-1.AS

Abstract

Our institution began using a stereotactic core needle breast biopsy system for mammographically detected breast lesions in November 1996. The system consists of a LORAD stereo imaging table and an 11-gauge vacuum-assisted mammotome (Biopsys Medical, Irvine, CA). All biopsies were performed with the combined efforts of a radiologist and a surgeon. Three hundred sixteen biopsies were attempted in 279 patients, with multiple biopsies in 31 patients. Indications included microcalcifications in 52 per cent of patients and a mass in 48 per cent of patients. Biopsy was unsuccessful in 20 patients (6.3%). Pathologic diagnoses included invasive ductal carcinoma (19 patients), invasive lobular carcinoma (2), ductal carcinoma in situ (17), atypical ductal hyperplasia (8), atypical lobular hyperplasia (1), fibroadenoma (40), lymph node (7), and benign (202). Invasive cancer, in situ carcinoma, or atypical hyperplasia was diagnosed in 46 (15.6%) lesions. Thirty-six patients had open biopsies. The core biopsy diagnosis was correct in 27 lesions, unable to be confirmed in six cases and changed in four cases, with three lesions upgraded and one case downgraded. The 11-gauge vacuum-assisted mammotome provides excellent accuracy for diagnosing mammographic abnormalities. A combined effort between radiology and surgical services is an effective way of using the stereotactic biopsy system.

Authors+Show Affiliations

Klem D
Department of Surgery, The Institute for Minimally Invasive Surgery, Central Dupage Hospital, Winfield, Illinois, USA.
Jacobs HK
No affiliation info available
Jorgensen R
No affiliation info available
Facenda LS
No affiliation info available
Baker DA
No affiliation info available
Altimari A
No affiliation info available

MeSH

AdultBiopsyBreastBreast NeoplasmsCarcinoma in SituCarcinoma, Ductal, BreastCarcinoma, LobularDiagnosis, DifferentialFemaleFibroadenomaHospitals, CommunityHumansHyperplasiaIllinoisMiddle AgedStereotaxic Techniques

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10432083

Citation

Klem, D, et al. "Stereotactic Breast Biopsy in a Community Hospital Setting." The American Surgeon, vol. 65, no. 8, 1999, pp. 737-40; discussion 740-1.
Klem D, Jacobs HK, Jorgensen R, et al. Stereotactic breast biopsy in a community hospital setting. Am Surg. 1999;65(8):737-40; discussion 740-1.
Klem, D., Jacobs, H. K., Jorgensen, R., Facenda, L. S., Baker, D. A., & Altimari, A. (1999). Stereotactic breast biopsy in a community hospital setting. The American Surgeon, 65(8), 737-40; discussion 740-1.
Klem D, et al. Stereotactic Breast Biopsy in a Community Hospital Setting. Am Surg. 1999;65(8):737-40; discussion 740-1. PubMed PMID: 10432083.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Stereotactic breast biopsy in a community hospital setting. AU - Klem,D, AU - Jacobs,H K, AU - Jorgensen,R, AU - Facenda,L S, AU - Baker,D A, AU - Altimari,A, PY - 1999/8/4/pubmed PY - 1999/8/4/medline PY - 1999/8/4/entrez SP - 737-40; discussion 740-1 JF - The American surgeon JO - Am Surg VL - 65 IS - 8 N2 - Our institution began using a stereotactic core needle breast biopsy system for mammographically detected breast lesions in November 1996. The system consists of a LORAD stereo imaging table and an 11-gauge vacuum-assisted mammotome (Biopsys Medical, Irvine, CA). All biopsies were performed with the combined efforts of a radiologist and a surgeon. Three hundred sixteen biopsies were attempted in 279 patients, with multiple biopsies in 31 patients. Indications included microcalcifications in 52 per cent of patients and a mass in 48 per cent of patients. Biopsy was unsuccessful in 20 patients (6.3%). Pathologic diagnoses included invasive ductal carcinoma (19 patients), invasive lobular carcinoma (2), ductal carcinoma in situ (17), atypical ductal hyperplasia (8), atypical lobular hyperplasia (1), fibroadenoma (40), lymph node (7), and benign (202). Invasive cancer, in situ carcinoma, or atypical hyperplasia was diagnosed in 46 (15.6%) lesions. Thirty-six patients had open biopsies. The core biopsy diagnosis was correct in 27 lesions, unable to be confirmed in six cases and changed in four cases, with three lesions upgraded and one case downgraded. The 11-gauge vacuum-assisted mammotome provides excellent accuracy for diagnosing mammographic abnormalities. A combined effort between radiology and surgical services is an effective way of using the stereotactic biopsy system. SN - 0003-1348 UR - https://www.unboundmedicine.com/medline/citation/10432083/Stereotactic_breast_biopsy_in_a_community_hospital_setting_ L2 - https://medlineplus.gov/breastcancer.html DB - PRIME DP - Unbound Medicine ER -